Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Pineal Cyst Apoplexy: A Rare Complication of Common Entity

Kim E, Kwon SM

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):66-70.
  • doi: 10.14791/btrt.2020.8.e4
Pineal cysts (PCs) are often encountered as incidental findings in intracranial images. The vast majority of cysts are normally asymptomatic and clinically benign. Bleeding into the cysts, which leads to neurological symptoms...
An Intracerebral Type of Cranial Chondroma

Kim E

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):62-65.
  • doi: 10.14791/btrt.2020.8.e8
The vast majority of intracranial chondromas are located in the base of the cranium. Their presentation as an intracerebral neoplasm is considered to be extremely rare. A previously healthy 45-year-old man experienced...
Sinonasal Teratocarcinosarcoma, a Rare Tumor Involving Boththe Nasal Cavity and the Cranial Cavity

Yoon SY, Park KS, Hwang JH, Park SH, Han MH

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):57-61.
  • doi: 10.14791/btrt.2020.8.e2
Sinonasal teratocarcinosarcoma (SNTCS), a very rare tumor, is known to be a heterogeneous with epithelial, mesenchymal, and neuroepithelial components and shows a very aggressive clinical course. Due to the heterogeneity of this...
Primary Gliosarcoma with Extracranial Metastasis

Choi MG, Lee JH, Lee MS, Suh SJ, Lee YS, Kang DG

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):53-56.
  • doi: 10.14791/btrt.2020.8.e9
A 69-year-old male presented with a week of worsening headache, mild dizziness and left side weakness, and the radiological work-up of his brain displayed an enhancing mass on the right frontal...
Inhibition of the Spectraplakin Protein Microtubule ActinCrosslinking Factor 1 Sensitizes Glioblastomas to Radiation

Bonner K, Borlay D, Kutten O, Quick QA

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):43-52.
  • doi: 10.14791/btrt.2020.8.e1
Background : Microtubule actin crosslinking factor 1 (MACF1) is a spectraplakin cytoskeletal crosslinking protein whose function and role in cancer biology has lacked investigation. Recent studies have identified MACF1 as a novel...
Comparison of Diagnostic Performance of Two-Dimensionaland Three-Dimensional Fractal Dimension and LacunarityAnalyses for Predicting the Meningioma Grade

Kim S, Park YW, Park SH, Ahn SS, Chang JH, Kim SH, Lee SK

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):36-42.
  • doi: 10.14791/btrt.2020.8.e3
Background : To compare the diagnostic performance of two-dimensional (2D) and three-dimensional (3D) fractal dimension (FD) and lacunarity features from MRI for predicting the meningioma grade. Methods : This retrospective study included...
Re-Irradiation and Its Contribution to Good Prognosisin Recurrent Glioblastoma Patients

Kim MS, Lim J, Shin HS, Cho KG

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):29-35.
  • doi: 10.14791/btrt.2020.8.e10
Background : Radiation therapy, one of the strongest anti-cancer treatments, is already performed to treat primary glioblastoma; however, the effect of repeated radiation therapy for recurrent tumors has not been fully explored....
A National Consensus Survey for Current Practicein Brain Tumor Management III: Brain Metastasis andPrimary Central Nervous System Lymphoma

Kim SK, Park JE, Kim KH, Cho JM, Moon J, Yoon WS, Kim SH, Kim YI, Kim YZ, Kim HS, Dho YS, Park JS, Yoon HI, Seo Y, Sung KS, Song JH, Wee CW, Lee SH, Lim DH, Im JH, Chang JH, Han MH, Hong JB, Hwang K, Park CK, Lee YS, Gwak HS, KSNO Guideline Working Group

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):20-28.
  • doi: 10.14791/btrt.2020.8.e7
Background : The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted the nationwide questionnaire survey for diverse queries facing to treat patients with brain tumor. As part III of...
A National Consensus Survey for Current Practicein Brain Tumor Management II:Diffuse Midline Glioma and Meningioma

Kim SK, Yoon HI, Yoon WS, Cho JM, Moon J, Kim KH, Kim SH, Kim YI, Kim YZ, Kim HS, Dho YS, Park JS, Park JE, Seo Y, Sung KS, Song JH, Wee CW, Lee SH, Lim DH, Im JH, Chang JH, Han MH, Hong JB, Hwang K, Park CK, Lee YS, Gwak HS, KSNO Guideline Working Group

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):11-19.
  • doi: 10.14791/btrt.2020.8.e6
Background : The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part II of...
A National Consensus Survey for Current Practicein Brain Tumor Management I: Antiepileptic Drug andSteroid Usage

Kim SK, Moon J, Cho JM, Kim KH, Kim SH, Kim YI, Kim YZ, Kim HS, Dho YS, Park JS, Park JE, Seo Y, Sung KS, Song JH, Wee CW, Yoon WS, Yoon HI, Lee SH, Lim DH, Im JH, Chang JH, Han MH, Hong JB, Hwang K, Park CK, Lee YS, Gwak HS, KSNO Guideline Working Group

  • Brain Tumor Res Treat.
  • 2020 Apr;8(1):1-10.
  • doi: 10.14791/btrt.2020.8.e5
Background : The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part I of...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr